{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:50:34Z","timestamp":1771102234687,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["535333"],"award-info":[{"award-number":["535333"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Moorfields Eye Charity"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12951-018-0425-3","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T02:45:42Z","timestamp":1543286742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF\/SRF inhibitor in conjunctival fibrosis"],"prefix":"10.1186","volume":"16","author":[{"given":"Aristides D.","family":"Tagalakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Madaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Neubig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng T.","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin Sheng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4868-5187","authenticated-orcid":false,"given":"Cynthia","family":"Yu-Wai-Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"issue":"6","key":"425_CR1","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1073\/pnas.1215498110","volume":"110","author":"GW Ashley","year":"2013","unstructured":"Ashley GW, Henise J, Reid R, Santi DV. Hydrogel drug delivery system with predictable and tunable drug release and degradation rates. Proc Natl Acad Sci USA. 2013;110(6):2318\u201323.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"4","key":"425_CR2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1208\/s12249-012-9832-1","volume":"13","author":"G Parkinson","year":"2012","unstructured":"Parkinson G, Gaisford S, Ru Q, Lockwood A, Khalili A, Sheridan R, et al. Characterisation of Ilomastat for prolonged ocular drug release. AAPS Pharm Sci Tech. 2012;13(4):1063\u201372.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"11","key":"425_CR3","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1021\/ci4002348","volume":"53","author":"Q Ru","year":"2013","unstructured":"Ru Q, Fadda HM, Li C, Paul D, Khaw PT, Brocchini S, et al. Molecular dynamic simulations of ocular tablet dissolution. J Chem Inf Model. 2013;53(11):3000\u20138.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"425_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.actbio.2007.09.011","volume":"4","author":"JJ Blaker","year":"2008","unstructured":"Blaker JJ, Knowles JC, Day RM. Novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery. Acta Biomater. 2008;4(2):264\u201372.","journal-title":"Acta Biomater"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1167\/iovs.12-11466","volume":"54","author":"Y-C Liu","year":"2013","unstructured":"Liu Y-C, Peng Y, Lwin NC, Wong TT, Venkatraman SS, Mehta JS. Optimization of subconjunctival biodegradable microfilms for sustained drug delivery to the anterior segment in a small animal model. Invest Ophthalmol Vis Sci. 2013;54:2607\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"425_CR6","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1167\/iovs.13-11777","volume":"54","author":"I Rodr\u00edguez-Agirretxe","year":"2013","unstructured":"Rodr\u00edguez-Agirretxe I, Vega SC, Rezola R, Vecino E, Mendicute J, Suarez-Cortes T, et al. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy. Invest Ophthalmol Vis Sci. 2013;54(8):5227\u201335.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"425_CR7","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390.","journal-title":"Ophthalmology"},{"issue":"11","key":"425_CR8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/jamaophthalmol.2017.3407","volume":"135","author":"C Yu-Wai-Man","year":"2017","unstructured":"Yu-Wai-Man C, Tagalakis AD, Meng JH, Bouremel Y, Lee RM, Virasami A, et al. Genotype-phenotype associations of IL-6 and PRG4 with conjunctival fibrosis after glaucoma surgery. JAMA Ophthalmol. 2017;135(11):1147\u201355.","journal-title":"JAMA Ophthalmol."},{"issue":"4","key":"425_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0092-8674(86)90882-2","volume":"46","author":"R Treisman","year":"1986","unstructured":"Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell. 1986;46(4):567\u201374.","journal-title":"Cell"},{"issue":"6","key":"425_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0092-8674(88)90244-9","volume":"55","author":"C Norman","year":"1988","unstructured":"Norman C, Runswick M, Pollock R, Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell. 1988;55(6):989\u20131003.","journal-title":"Cell"},{"issue":"10","key":"425_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0968-0004(92)90013-Y","volume":"17","author":"R Treisman","year":"1992","unstructured":"Treisman R. The serum response element. Trends Biochem Sci. 1992;17(10):423\u20136.","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"425_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1101\/gad.239327.114","volume":"28","author":"C Esnault","year":"2014","unstructured":"Esnault C, Stewart A, Gualdrini F, East P, Horswell S, Matthews N, et al. Rho\u2013actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev. 2014;28(9):943\u201358.","journal-title":"Genes Dev"},{"issue":"5","key":"425_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrm2890","volume":"11","author":"EN Olson","year":"2010","unstructured":"Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol. 2010;11(5):353\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"425_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1124\/jpet.114.213520","volume":"349","author":"AJ Haak","year":"2014","unstructured":"Haak AJ, Tsou PS, Amin MA, Ruth JH, Campbell P, Fox DA, et al. Targeting the myofibroblast genetic switch: inhibitors of MRTF\/SRF-regulated gene transcription prevent fibrosis in a murine model of skin injury. J Pharmacol Exp Ther. 2014;349(3):480\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"23","key":"425_CR15","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1038\/emboj.2012.296","volume":"31","author":"T Minami","year":"2012","unstructured":"Minami T, Kuwahara K, Nakagawa Y, Takaoka M, Kinoshita H, Nakao K, et al. Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice. EMBO J. 2012;31(23):4428\u201340.","journal-title":"EMBO J"},{"issue":"4","key":"425_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ajpath.2014.12.005","volume":"185","author":"TH Sisson","year":"2015","unstructured":"Sisson TH, Ajayi IO, Subbotina N, Dodi AE, Rodansky ES, Chibucos LN, et al. Inhibition of myocardin-related transcription factor\/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. Am J Pathol. 2015;185(4):969\u201386.","journal-title":"Am J Pathol"},{"key":"425_CR17","doi-asserted-by":"publisher","first-page":"21881","DOI":"10.1038\/srep21881","volume":"6","author":"C Yu-Wai-Man","year":"2016","unstructured":"Yu-Wai-Man C, Tagalakis AD, Manunta MD, Hart SL, Khaw PT. Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis. Sci Rep. 2016;6:21881.","journal-title":"Sci Rep."},{"key":"425_CR18","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.1141084","volume":"316","author":"MK Vartiainen","year":"2007","unstructured":"Vartiainen MK, Guettler S, Larijani B, Treisman R. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science. 2007;316:1749\u201352.","journal-title":"Science"},{"key":"425_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0092-8674(03)00278-2","volume":"113","author":"F Miralles","year":"2003","unstructured":"Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 2003;113:329\u201342.","journal-title":"Cell"},{"issue":"1","key":"425_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41598-017-00212-w","volume":"7","author":"C Yu-Wai-Man","year":"2017","unstructured":"Yu-Wai-Man C, Spencer-Dene B, Lee RMH, Hutchings K, Lisabeth EM, Treisman R, et al. Local delivery of novel MRTF\/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis. Sci Rep. 2017;7(1):518.","journal-title":"Sci Rep."},{"issue":"3","key":"425_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2009.02.020","volume":"136","author":"K Hironaka","year":"2009","unstructured":"Hironaka K, Inokuchi Y, Tozuka Y, Shimazawa M, Hara H, Takeuchi H. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Control Rel. 2009;136(3):247\u201353.","journal-title":"J Control Rel"},{"key":"425_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.actbio.2017.01.048","volume":"51","author":"AD Tagalakis","year":"2017","unstructured":"Tagalakis AD, Maeshima R, Yu-Wai-Man C, Meng J, Syed F, Wu LP, et al. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: targetable nanocomplexes for in vivo nucleic acid delivery. Acta Biomater. 2017;51:351\u201362.","journal-title":"Acta Biomater"},{"key":"425_CR23","first-page":"2225","volume":"40","author":"MF Cordeiro","year":"1999","unstructured":"Cordeiro MF, Gay J, Khaw PT. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci. 1999;40:2225\u201334.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"425_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1167\/iovs.02-0366","volume":"44","author":"TTL Wong","year":"2003","unstructured":"Wong TTL, Mead AL, Khaw PT. Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2003;44(3):1097\u2013103.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"425_CR25","doi-asserted-by":"publisher","first-page":"8406","DOI":"10.1016\/j.biomaterials.2014.06.003","volume":"35","author":"AD Tagalakis","year":"2014","unstructured":"Tagalakis AD, Lee DHD, Bienemann AS, Zhou H, Munye MM, Saraiva L, et al. Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery. Biomaterials. 2014;35:8406\u201315.","journal-title":"Biomaterials"},{"issue":"2","key":"425_CR26","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1038\/mtna.2013.22","volume":"4","author":"J McCaskill","year":"2013","unstructured":"McCaskill J, Singhania R, Burgess M, Allavena R, Wu S, Blumenthal A, et al. Efficient, biodistribution and gene silencing in the lung epithelium via intravenous liposomal delivery of siRNA. Mol Ther Nucleic Acids. 2013;4(2):e96. \n                    https:\/\/doi.org\/10.1038\/mtna.2013.22\n                    \n                  .","journal-title":"Mol Ther Nucleic Acids."},{"issue":"1","key":"425_CR27","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1038\/s41467-018-05118-3","volume":"9","author":"W Deng","year":"2018","unstructured":"Deng W, Chen W, Clement S, Guller A, Zhao Z, Engel A, et al. Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation. Nat Commun. 2018;9(1):2713. \n                    https:\/\/doi.org\/10.1038\/s41467-018-05118-3\n                    \n                  .","journal-title":"Nat Commun."},{"issue":"1","key":"425_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1586\/17469899.2015.983475","volume":"10","author":"C Yu-Wai-Man","year":"2015","unstructured":"Yu-Wai-Man C, Khaw PT. Developing novel anti-fibrotic therapeutics to modulate post-surgical wound healing in glaucoma: big potential for small molecules. Expert Rev Ophthalmol. 2015;10(1):65\u201376.","journal-title":"Expert Rev Ophthalmol."},{"issue":"1","key":"425_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/pt0801001","volume":"8","author":"RM Hathout","year":"2007","unstructured":"Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharm Sci Tech. 2007;8(1):1.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"9","key":"425_CR30","doi-asserted-by":"publisher","first-page":"e24513","DOI":"10.1371\/journal.pone.0024513","volume":"6","author":"JV Natarajan","year":"2011","unstructured":"Natarajan JV, Chattopadhyay S, Ang M, Darwitan A, Foo S, Zhen M, et al. Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye. PLoS ONE. 2011;6(9):e24513.","journal-title":"PLoS ONE"},{"issue":"3","key":"425_CR31","doi-asserted-by":"publisher","first-page":"E371","DOI":"10.1208\/aapsj0903044","volume":"9","author":"Y Shen","year":"2007","unstructured":"Shen Y, Tu J. Preparation and ocular pharmacokinetics of ganciclovir liposomes. AAPS J. 2007;9(3):E371\u20137.","journal-title":"AAPS J"},{"key":"425_CR32","first-page":"123","volume":"7","author":"JV Natarajan","year":"2012","unstructured":"Natarajan JV, Ang M, Darwitan A, Chattopadhyay S, Wong TT, Venkatraman SS. Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. Int J Nanomed. 2012;7:123\u201331.","journal-title":"Int J Nanomed."},{"key":"425_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1073\/pnas.0234057100","volume":"100","author":"N Suzuki","year":"2003","unstructured":"Suzuki N, Nakamura S, Mano H, Kozasa T. Ga12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc Natl Acad Sci USA. 2003;100:733\u20138.","journal-title":"Proc Natl Acad Sci USA."},{"key":"425_CR34","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1158\/1535-7163.MCT-06-0782","volume":"6","author":"CR Evelyn","year":"2007","unstructured":"Evelyn CR, Wade SM, Wang Q, Wu M, Iniguez-Lluh\u0131 JA, Merajver SD, et al. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther. 2007;6:2249\u201360.","journal-title":"Mol Cancer Ther"},{"key":"425_CR35","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1016\/j.bmcl.2013.04.080","volume":"23","author":"JL Bell","year":"2013","unstructured":"Bell JL, Haak AJ, Wade SM, Kirchhoff PD, Neubig RR, Larsen SD. Optimization of novel nipecotic bis(amide) inhibitors of the Rho\/MKL1\/SRF transcriptional pathway as potential anti-metastasis agents. Bioorg Med Chem Lett. 2013;23:3826\u201332.","journal-title":"Bioorg Med Chem Lett"},{"key":"425_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.bmcl.2009.11.056","volume":"20","author":"CR Evelyn","year":"2010","unstructured":"Evelyn CR, Bell JL, Ryu JG, Wade SM, Kocab A, Harzdorf NL, et al. Design, synthesis and prostate cancer cell-based studies of analogs of the Rho\/MKL1 transcriptional pathway inhibitor, CCG-1423. Bioorg Med Chem Lett. 2010;20:665\u201372.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"425_CR37","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.bmcl.2017.02.070","volume":"27","author":"KM Hutchings","year":"2017","unstructured":"Hutchings KM, Lisabeth EM, Rajeswaran W, Wilson MW, Sorenson RJ, Campbell PL, et al. Pharmacokinetic optimitzation of CCG-203971: novel inhibitors of the Rho\/MRTF\/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma. Bioorg Med Chem Lett. 2017;27(8):1744\u20139.","journal-title":"Bioorg Med Chem Lett"},{"key":"425_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2013.12.035","volume":"156","author":"MR Lundquist","year":"2014","unstructured":"Lundquist MR, Storaska AJ, Liu TC, Larsen SD, Evans T, Neubig RR, et al. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. Cell. 2014;156:563\u201376.","journal-title":"Cell"},{"issue":"2","key":"425_CR39","doi-asserted-by":"publisher","first-page":"e89016","DOI":"10.1371\/journal.pone.0089016","volume":"9","author":"K Hayashi","year":"2014","unstructured":"Hayashi K, Watanabe B, Nakagawa Y, Minami S, Morita T. RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling. PLoS ONE. 2014;9(2):e89016.","journal-title":"PLoS ONE"},{"key":"425_CR40","first-page":"449","volume":"39","author":"JG Crowston","year":"1998","unstructured":"Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT. Antimetabolites-induced apoptosis in Tenon\u2019s capsule fibroblasts. Invest Ophthalmol Vis Sci. 1998;39:449\u201354.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"425_CR41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archopht.1992.01080200029011","volume":"110","author":"HD Jampel","year":"1992","unstructured":"Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol. 1992;110:1049\u201350.","journal-title":"Arch Ophthalmol"},{"key":"425_CR42","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0161-6420(96)30527-7","volume":"103","author":"R Parrish","year":"1996","unstructured":"Parrish R, Minckler D. \u201cLate endophthalmitis\u201d: filtering surgery time bomb? Ophthalmology. 1996;103:1167\u20138.","journal-title":"Ophthalmology"},{"issue":"5","key":"425_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00003226-199609000-00015","volume":"15","author":"PJ Dougherty","year":"1996","unstructured":"Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea. 1996;15(5):537\u201340.","journal-title":"Cornea"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-018-0425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-018-0425-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-018-0425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T19:13:11Z","timestamp":1574795591000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-018-0425-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1186\/s12951-018-0425-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"9 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"97"}}